Qingyi Wei

773 total citations
26 papers, 542 citations indexed

About

Qingyi Wei is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Qingyi Wei has authored 26 papers receiving a total of 542 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 9 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Qingyi Wei's work include DNA Repair Mechanisms (10 papers), RNA modifications and cancer (6 papers) and BRCA gene mutations in cancer (4 papers). Qingyi Wei is often cited by papers focused on DNA Repair Mechanisms (10 papers), RNA modifications and cancer (6 papers) and BRCA gene mutations in cancer (4 papers). Qingyi Wei collaborates with scholars based in United States, China and France. Qingyi Wei's co-authors include Gary L. Clayman, Erich M. Sturgis, Sara S. Strom, Lei Li, Margaret R. Spitz, Susan A. Eicher, Rong Zheng, Christopher I. Amos, Kavita Y. Sarin and Jiali Han and has published in prestigious journals such as Scientific Reports, International Journal of Cancer and Journal of Investigative Dermatology.

In The Last Decade

Qingyi Wei

26 papers receiving 527 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qingyi Wei United States 11 419 176 141 90 71 26 542
Gustavo Jacob Lourenço Brazil 16 356 0.8× 124 0.7× 148 1.0× 77 0.9× 80 1.1× 82 598
Hsien-Chang Tseng Taiwan 10 382 0.9× 148 0.8× 173 1.2× 80 0.9× 49 0.7× 13 591
Marcin Szaumkessel Poland 14 416 1.0× 195 1.1× 83 0.6× 49 0.5× 44 0.6× 18 533
Katarzyna Kiwerska Poland 13 428 1.0× 166 0.9× 102 0.7× 38 0.4× 40 0.6× 35 558
Tahia Sellami‐Boudawara Tunisia 17 388 0.9× 147 0.8× 233 1.7× 110 1.2× 93 1.3× 48 661
Shigenori Furukawa Japan 12 162 0.4× 115 0.7× 138 1.0× 27 0.3× 27 0.4× 42 449
Suocheng Chen China 12 343 0.8× 192 1.1× 81 0.6× 82 0.9× 34 0.5× 36 528
Shi‐Juan Mai China 15 375 0.9× 225 1.3× 133 0.9× 51 0.6× 12 0.2× 32 572
Chih Yi Chen Taiwan 8 328 0.8× 138 0.8× 205 1.5× 65 0.7× 37 0.5× 14 491
Sheila Coelho Soares‐Lima Brazil 16 398 0.9× 155 0.9× 129 0.9× 22 0.2× 36 0.5× 48 584

Countries citing papers authored by Qingyi Wei

Since Specialization
Citations

This map shows the geographic impact of Qingyi Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingyi Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingyi Wei more than expected).

Fields of papers citing papers by Qingyi Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingyi Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingyi Wei. The network helps show where Qingyi Wei may publish in the future.

Co-authorship network of co-authors of Qingyi Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Qingyi Wei. A scholar is included among the top collaborators of Qingyi Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingyi Wei. Qingyi Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cao, Ji, Yanji Jiang, Yingchun Liu, et al.. (2024). Functional genetic variants of the disulfidptosis-relatedINF2gene predict survival of hepatitis B virus-related hepatocellular carcinoma. Carcinogenesis. 45(4). 199–209. 3 indexed citations
2.
Cheng, Lei, Qi Liu, Genming Zhao, et al.. (2022). Potentially functional genetic variants of VAV2 and PSMA4 in the immune‐activation pathway and non‐small cell lung cancer survival. The Journal of Gene Medicine. 24(10). e3447–e3447. 5 indexed citations
3.
Qian, Danwen, Hongliang Liu, Lingling Zhao, et al.. (2021). A pleiotropic ATM variant (rs1800057 C>G) is associated with risk of multiple cancers. Carcinogenesis. 43(1). 60–66. 2 indexed citations
4.
Li, Haoran, Hong Dai, Tingyan Shi, et al.. (2020). Functional genetic variants of CTNNBIP1 predict platinum treatment response of Chinese epithelial ovarian cancer patients. Journal of Cancer. 11(23). 6850–6860. 7 indexed citations
5.
Cheng, Lei, Qi Liu, Mengyun Wang, et al.. (2020). Genetic variants in the human leukocyte antigen region and survival of Chinese patients with non-small cell lung carcinoma. Carcinogenesis. 41(9). 1203–1212. 4 indexed citations
6.
Li, Haoran, Hong Dai, Tingyan Shi, et al.. (2020). Potentially functional variants in nucleotide excision repair pathway genes predict platinum treatment response of Chinese ovarian cancer patients. Carcinogenesis. 41(9). 1229–1237. 5 indexed citations
7.
Feng, Yun, Hongliang Liu, Bensong Duan, et al.. (2019). Potential functional variants in SMC2 and TP53 in the AURORA pathway genes and risk of pancreatic cancer. Carcinogenesis. 40(4). 521–528. 17 indexed citations
8.
Li, Haoran, Yuan Xu, Mengyun Wang, et al.. (2019). Functional genetic variants of RUVBL1 predict overall survival of Chinese patients with epithelial ovarian cancer. Carcinogenesis. 40(10). 1209–1219. 7 indexed citations
9.
Wang, Xiaomeng, Hongliang Liu, Yinghui Xu, et al.. (2018). Genetic variants in the calcium signaling pathway genes are associated with cutaneous melanoma-specific survival. Carcinogenesis. 40(2). 279–288. 7 indexed citations
10.
Shi, Tingyan, Pan Wang, Rong Jiang, et al.. (2018). Survival Benefit of Germline BRCA Mutation is Associated with Residual Disease in Ovarian Cancer. Cellular Physiology and Biochemistry. 47(5). 2088–2096. 10 indexed citations
11.
Wu, Wenting, Christopher I. Amos, Jeffrey E. Lee, et al.. (2018). Inverse Relationship between Vitiligo-Related Genes and Skin Cancer Risk. Journal of Investigative Dermatology. 138(9). 2072–2075. 21 indexed citations
12.
Nagel, Zachary D., Bevin P. Engelward, David J. Brenner, et al.. (2017). Towards precision prevention: Technologies for identifying healthy individuals with high risk of disease. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 800-802. 14–28. 23 indexed citations
13.
Zhang, Ruoxin, Ming Jia, Yuan Xu, et al.. (2017). Genetic variants in ERCC1 and XPC predict survival outcome of non-small cell lung cancer patients treated with platinum-based therapy. Scientific Reports. 7(1). 10702–10702. 11 indexed citations
14.
Yuan, Ying, Erich M. Sturgis, Lijun Zhu, et al.. (2016). A functional variant at the miRNA binding site in E2F1 gene is associated with risk and tumor HPV16 status of oropharynx squamous cell carcinoma. Molecular Carcinogenesis. 56(3). 1100–1106. 14 indexed citations
15.
Gu, Chengyuan, Yongxue Zhu, Yuan Qu, et al.. (2015). Genetic variants in the TEP1 gene are associated with prostate cancer risk and recurrence. Prostate Cancer and Prostatic Diseases. 18(4). 310–316. 8 indexed citations
16.
Zhang, Haishi, Yanhong Liu, Keke Zhou, et al.. (2015). Genetic variations in the homologous recombination repair pathway genes modify risk of glioma. Journal of Neuro-Oncology. 126(1). 11–17. 9 indexed citations
18.
Chen, Lei, Chao Wang, Qingyi Wei, Ning Zheng-xiang, & Erdong Yuan. (2013). Interaction of dihydromyricetin and alpha-amylase.. PubMed. 8(3). 339–42. 5 indexed citations
19.
Sturgis, Erich M., Gary L. Clayman, Yongli Guan, Zhaozheng Guo, & Qingyi Wei. (1999). DNA Repair in Lymphoblastoid Cell Lines From Patients With Head and Neck Cancer. Archives of Otolaryngology - Head and Neck Surgery. 125(2). 185–185. 20 indexed citations
20.
Sturgis, Erich M., Lei Li, Rong Zheng, et al.. (1999). Polymorphisms of DNA repair gene XRCC1 in squamous cell carcinoma of the head and neck. Carcinogenesis. 20(11). 2125–2129. 273 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026